直播預告｜JCRQ1期刊主編在線分享！

直播時間：2024年8月21日（周三）18:00——20:00

直播平臺：

科學網APP

https://weibo.com/l/wblive/p/show/1022:2321325067673620054185（科學網微博直播間鏈接）

科學網微博

科學網視頻號

【直播簡介】

2024年08月21日，Frontiers Conversations（前沿面對面）線上活動將于北京時間18:00和大家見面。Frontiers Conversations 是由 Frontiers 主辦的系列在線研討會，該活動將定期邀請領域內專家就學術進展和期刊發展等熱點話題與廣大學者進行分享與交流。

本期Frontiers Conversations 邀請到Frontiers in Medicine(IF: 3.1｜CiteScore: 5.1)期刊主編（Field Chief Editor）布魯塞爾自由大學（Institut pour lInnovation Interdisciplinaire en Santé, Université Libre de Bruxelles）的Michel Goldman教授、期刊欄目主編（Specialty Chief Editor）復旦大學附屬中山醫院的白春學教授，浙江大學醫學院附屬邵逸夫醫院的章仲恒教授和期刊欄目助理主編（Assistant Specialty Chief Editor）復旦大學附屬中山醫院的楊達偉教授 四位將圍繞Best Practices to Publish in Frontiers in Medicine展開分享。

【主講嘉賓】

Michel Goldman Professor

Institut pour lInnovation Interdisciplinaire en Santé, Université Libre de Bruxelles

Michel Goldman, MD, PhD, is the Founding President of the Institute for Interdisciplinary Innovation in healthcare at the Université libre de Bruxelles. He currently serves as Field Chief Editor of the journal Frontiers in Medicine and was the first Executive Director of the European Innovative Medicines Initiative from 2009 to 2014. He is a member of the Royal Academy of Medicine of Belgium and of the National Academy of Pharmacy in France.

Author of over 450 scientific publications in the fields of clinical medicine and immunology, he now works with Belgian and French economists on issues of innovation and access to medicines. He is the author of the book "La médecine daprès, le?ons du Covid-19", published by the Académie Royale de Belgique, and edited the collective work "Les vaccins, ce que tu dois savoir".

Michel Goldman is a laureate of the Lucien Steinberg Prize (shared with Pr. Peter Piot, 1997), of the Quinquennial Prize of the Belgian National Fund of Scientific Research (2000), and of the Spinoza chair at the University of Amsterdam (2001). In 2007, he was awarded the degree of Doctor Honoris Causa of the Université of Lille. In 2024, Michel Goldman was the recipient of the Blaise Pascal Medal for Medicine and Life Sciences awarded by the European Academy of Sciences.

[分享主題]

Best practices to publish in Frontiers in Medicine

In this presentation, we will first underline the key features of Frontiers in Medicine, emphasizing that the journal is the right vehicle for open access publishing of original innovative findings and key messages relevant to clinical practice and patient care.

As a multidisciplinary journal, Frontiers in Medicine is organized in sections dedicated to the following areas of modern medicine: dermatology, family medicine and primary care, gastroenterology, gene and cell therapy, geriatric medicine, healthcare professions education, hematology, hepatobiliary diseases; infectious diseases: pathogenesis and therapy, intensive care medicine and anesthesiology, nephrology, nuclear medicine, obstetrics and gynecology, ophthalmology, pathology, precision medicine, pulmonary medicine, regulatory science, rheumatology and translational medicine. Each section is led by a Specialty Chief Editor.

We will explain the different types of papers that can be considered, focusing on original research articles.

We will then review the different steps to follow in preparing a paper, including:

1. Identify the key novel messages that you wish to deliver on a given topic

2. Identify the appropriate section of the journal where the paper will be submitted

3. Understand the journal’s requirement

4. Perform a comprehensive literature review on existing knowledge in the field, to document the novelty of your findings and message.

5. Ensure that your data are robust and reproducible

6. Check that all ethical requirements are fulfilled

7. Organize your paper as follows:

a. Title: must be concise, informative, and catchy

b. Abstract: It should tell prospective readers the objective of your research and what the important findings of your work are. It should summarize the methods, the results obtained and the conclusions reached.

c. Introduction: should explain the scope of the research, what is already known in the field and state the objectives of your study.

d. Methods: Should describe the study design and the interventions, Data collection. and data analysis in detail.

e. Results: Present your findings clearly and logically, using tables and figures where appropriate.

f. Discussion: Interpret your results, discuss their implications, and relate them to existing knowledge. Address limitations and suggest areas for future research.

g. Conclusion: Summarize the main findings and their significance.

白春學 教授

復旦大學附屬中山醫院

復旦大學附屬中山醫院終身榮譽教授，現任上海市呼吸病研究所所長，中國肺癌防治聯盟主席，國際元宇宙醫學協會（ https://www.iamm.org.cn）主席，上海市控煙協會會長、《Clinicale-Health》和《元宇宙醫學》雜志主編、Frontiersin Medicine 呼吸病學欄目主編和 AJRCCM 等編委。獲國家自然科學基金重大、重點和面上等支持，牽頭亞太肺結節指南等國內外共識指南 30 項，獲批專利 50 項，研發成功全球首個數字人醫學 GPT（獲批注冊商標 7 項）和 HZ 肺結節和 OSA 評估管理一體機，發表論著 700 篇，含 SCI 期刊 320 篇，IF> 1700，引用>2萬次，h-指數 55，主編《未來已來-我們需要的元宇宙醫學》、《物聯網醫學》、《現代呼吸病學》、《Health 4.0》等中英文專著 12 部。

楊達偉 副主任醫師、副研究員

復旦大學附屬中山醫院

復旦大學附屬中山醫院副主任醫師、副研究員，上海呼吸物聯網醫學工程技術研究中心副主任，上海市呼吸病研究所物聯網醫學研究室副主任，國際肺癌研究協會（IASLC）預防、篩查和早期檢測委員會委員，獲國家自然科學面上、福建省杰出青年基金、上海市浦江人才計劃等支持，牽頭國際元宇宙醫學指南等國內外共識指南7項，獲批專利 15 項，發表論著 109 篇，其中 SCI期刊 61 篇，IF> 500，引用>1500次，h-指數 22，在國內首先開設元宇宙醫學課程（復旦大學通識核心課程）。

章仲恒 主任醫師、副教授

浙江大學醫學院附屬邵逸夫醫院

醫學博士，主任醫師/副教授，特聘研究員，博士生導師；浙江大學醫學院附屬邵逸夫醫院急診醫學科副主任；浙江大學急救醫學研究所副所長；浙江省醫師協會急診分會委員、浙江省醫學會急診青年委員。

主要從事急危重癥的臨床大數據科研工作，近年來已先后在 ICM、CCM 等權威期刊發表 SCI 論著 60 多篇，被引超過 8000 次，H 指數 42。Frontiers in Medicine 欄目主編；Computers in Biology and Medicine、Renal Failure等期刊編委；BMJ、Lancet Respiratory medicine、Critical Care Medicine、ICM 等雜志審稿人。

主持大數據人工智能方向國家自然科學基金2項，科技部重點研發(子)課題 2 項；入選浙江大學醫學院臨床拔尖人才培育計劃、浙江省醫壇新秀培育項目、入選2021/2022 愛思唯爾高被引學者。

Frontiers

Josh Kellie先生

Frontiers in Medicine

Josh is the Journal Manager of Frontiers in Medicine, leading a publishing team of 35 experts, running commissioning, research ethics & peer review. He works with a team of 26 Chief Editors across 20 medical disciplines to define the strategic direction of the journal.

Josh has a Masters of Natural Science from the University of Cambridge, and has previously managed several of Frontiers physical science and engineering products, including Frontiers in Nanotechnology and Frontiers in Energy Research. His main interests in academic publishing are tackling interdisciplinary topics and making his journals as inclusive as possible.

李雅楠女士

Frontiers 醫學與腦科學組

Yanan Li holds a Master of Public Health from Brown University. Yanan joined Frontiers in 2020 as a Content Specialist and has since progressed to the role of Content Manager in 2022, overseeing a team and contributing to the strategic business growth and scientific success of Health and Biomedical journals. During a maternity cover term as Customer Experience Manager, Yanan led initiatives to strengthen customer relations and ensure research integrity.

【期刊簡介】

Frontiers in Medicine 是瑞士出版社 Frontiers 旗下的開放獲取期刊。本刊出版經過嚴格同行評審的醫學相關文章，涵蓋了廣泛的醫學領域，旨在提高臨床實踐和病人護理，強調將科學進展轉化為新的治療方法或診斷工具的研究。該期刊重點介紹將基礎研究與臨床應用相結合的研究，特別是那些直接影響病人護理的研究。

期刊主要關注以下 20 個方向：